Chemotherapy-Induced Anemia in Adults: Incidence and Treatment von Groopman, Jerome E., Itri, Loretta M.

Volltext

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer von Bardia, A., Tolaney, S.M., Punie, K., Loirat, D., Oliveira, M., Kalinsky, K., Zelnak, A., Aftimos, P., Dalenc, F., Sardesai, S., Hamilton, E., Sharma, P., Recalde, S., Gil, E.C., Traina, T., O’Shaughnessy, J., Cortes, J., Tsai, M., Vahdat, L., Diéras, V., Carey, L.A., Rugo, H.S., Goldenberg, D.M., Hong, Q., Olivo, M., Itri, L.M., Hurvitz, S.A.

Volltext

Impact of Cancer‐Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition von Curt, Gregory A., Breitbart, William, Cella, David, Groopman, Jerome E., Horning, Sandra J., Itri, Loretta M., Johnson, David H., Miaskowski, Christine, Scherr, Susan L., Portenoy, Russell K., Vogelzang, Nicholas J.

Volltext

Erythropoietin Crosses the Blood-Brain Barrier to Protect against Experimental Brain Injury von Brines, Michael L., Ghezzi, Pietro, Keenan, Sonja, Agnello, Davide, De Lanerolle, Nihal C., Cerami, Carla, Itri, Loretta M., Cerami, Anthony

Volltext

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid) von Warrell, Raymond P, Frankel, Stanley R, Miller, Wilson H, Scheinberg, David A, Itri, Loretta M, Hittelman, Walter N, Vyas, Rohini, Andreeff, Michael, Tafuri, Agostino, Jakubowski, Ann, Gabrilove, Janice, Gordon, Michael S, Dmitrovsky, Ethan

Volltext

Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck von Hong, Waun KI, Lippman, Scott M, Itri, Loretta M, Karp, Daniel D, Lee, Jin S, Byers, Robert M, Schantz, Stimson P, Kramer, Alan M, Lotan, Reuben, Peters, Lester J, Dimery, Isaiah W, Brown, Barry W, Goepfert, Helmuth

Volltext

13-cis-Retinoic Acid in the Treatment of Oral Leukoplakia von Hong, Waun Ki, Endicott, James, Itri, Loretta M, Doos, Wilhelm, Batsakis, John G, Bell, Richard, Fofonoff, Stephanie, Byers, Robert, Atkinson, E. Neely, Vaughan, Charles, Toth, Bela B, Kramer, Alan, Dimery, Isaiah W, Skipper, Paulette, Strong, Stuart

Volltext

The interferons von ITRI, L. M

Volltext

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies von Steis, Ronald G, Smith, John W, Urba, Walter J, Clark, Jeffrey W, Itri, Loretta M, Evans, Lydia M, Schoenberger, Carolyn, Longo, Dan L

Volltext

Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Onc... von M J O'Connell, J P Colgan, M M Oken, R E Ritts, Jr, N E Kay, L M Itri

Volltext

Cancer‐Related Fatigue: Guidelines for Evaluation and Management von Portenoy, Russell K., Itri, Loretta M.

Volltext

Recombinant interferon alfa-2a in metastatic renal cell carcinoma: assessment of antitumor activity and anti-interferon antibody formation von Figlin, R A, deKernion, J B, Mukamel, E, Palleroni, A V, Itri, L M, Sarna, G P

Volltext

LBA55Initial results from TROPHY-U-01: A phase II open-label study of sacituzumab govitecan in patients (Pts) with metastatic urothelial cancer (mUC) after failure of platinum-base... von Tagawa, S T, Balar, A, Petrylak, D P, Grivas, P, Agarwal, N, Sternberg, C N, Hong, Q, Gladden, A, Kanwal, C, Siemon-Hryczyk, P, Goswami, T, Itri, L M, Loriot, Y

Volltext

13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin von Lippman, S M, Parkinson, D R, Itri, L M, Weber, R S, Schantz, S P, Ota, D M, Schusterman, M A, Krakoff, I H, Gutterman, J U, Hong, W K

Volltext

Cancer chemoprevention von Itri, Loretta M.

Volltext

Cancer‐related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy von ITRI, Loretta M

Volltext

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma von Creagan, E T, Ahmann, D L, Green, S J, Long, H J, Frytak, S, O'Fallon, J R, Itri, L M

Volltext

Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients von Kurzrock, R, Rosenblum, M G, Quesada, J R, Sherwin, S A, Itri, L M, Gutterman, J U

Volltext

Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma von Creagan, E T, Ahmann, D L, Green, S J, Long, H J, Frytak, S, Itri, L M

Volltext

Recombinant leukocyte a interferon (rIFN‐αA) in the treatment of disseminated malignant melanoma: Analysis of complete and long‐term responding patients von Creagan, Edward T., Ahmann, David L., Frytak, Stephen, Long, Harry J., Itri, Loretta M.

Volltext